Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
FDA approves Pfizer RSV vaccine for older adults
Jun 01, 2023
The CDC is expected to meet later in the month to adopt vaccine recommendations for older Americans.
COVID-19 vaccine primary series coverage 76 percent in adults 60 years and older
Feb 06, 2023
Primary series coverage by the end of 2022 was below the 100% target set for at-risk populations.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
First needle-free COVID-19 vaccines receive approval in India, China
Sep 07, 2022
Nasal and inhaled vaccines place doses directly where the virus enters the body, such as in the nose or mouth.
COVID-19 vaccination does not negatively impact fertility
Aug 24, 2022
The findings were seen for women undergoing in vitro fertilization-fresh embryo transfer cycle.
Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.